We are searching data for your request:
Greens call for legalization of cannabis drugs
The medical use of cannabis should be significantly simplified according to the will of the parliamentary group of Bündnis 90 / Die Grünen. Anyone who used cannabis extract or the flowers of the hemp plants to alleviate health problems should be exempted from criminal prosecution. So far, the Narcotics Act stipulates that legal measures are taken against those affected because of the possession of the cannabis products, even if medical use has been proven.
The Greens want to change this with a new draft law. In their current application (17/6127), they demand that the medically indicated use of cannabis be legalized and thus free those affected from a legal gray area. Access to cannabis medicines should be significantly improved and the prosecution of those who are already at risk of health should be stopped, according to the Greens. So far, the Federal Institute for Drugs and Medical Devices (BfArM) has only approved the medical use and thus the purchase of cannabis extracts or cannabis flowers in absolute exceptional cases.
Simplify medical use of cannabis products According to the Alliance 90 / The Greens bill, medical access to cannabis medicines is to be significantly simplified and exempted from drug law enforcement. So far, even with medical indications of cannabis medication, patients have only received an approval from the Federal Institute for Drugs and Medical Devices (BfArM) for the purchase of cannabis extracts or cannabis flowers from the pharmacy in absolute exceptional cases, according to the Greens' justification for their current draft law . Although numerous studies clearly prove that cannabis medication for serious diseases such as epilepsy, HIV, cancer, multiple sclerosis and chronic pain can bring about significant improvements in terms of patients, the legislation has so far lagged behind here, the Greens explain in their application . In particular, the pain-reducing effect of cannabis medication has been clearly proven and should also be taken into account in the case law. Based on the results of the study to date, a compilation of the medical recommendations for cannabis use must also be made in order to enable a clear limitation of legal cannabis use. According to the wishes of the Greens, the costs of medication with cannabis products should then be borne by the health insurance companies.
Patients become repeat offenders through the use of cannabis So far, the needy patients have had to bear the costs of 1,500 euros for the medically indicated use of cannabis medication, as outlined in the draft law. In addition, the purchase of cannabis products, such as dronabinol, cannabis flowers or cannabis extracts, has so far been subject to the Narcotics Act (BtMG), so that the needy are always in a legal gray area or are committed to criminal acts. Despite the medical use of cannabis products, it is not uncommon for criminal proceedings to be initiated against patients, the cessation of which is regularly imposed on cessation of cannabis use. However, since those affected are dependent on cannabis medication to alleviate their health complaints, it is difficult for them to do without them and would relatively often become repeat offenders in the legal sense, according to the current draft law of the Greens. Those affected face severe fines and even imprisonment. According to Bündnis 90 / Die Grünen, this is an intolerable condition, since the patients would be unnecessarily burdened in addition to their existing physical and psychological suffering. (fp)
Cannabis medication allowed in Germany
Researchers recommend cannabis for cancer
Photo credit: Susanne Schmich / pixelio.de